Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug 23:423:135-40.
doi: 10.1016/j.cca.2013.04.009. Epub 2013 Apr 27.

Evaluation of four different equations for calculating LDL-C with eight different direct HDL-C assays

Affiliations

Evaluation of four different equations for calculating LDL-C with eight different direct HDL-C assays

Marcelo Jose Andrade Oliveira et al. Clin Chim Acta. .

Abstract

Background: Low-density lipoprotein cholesterol (LDL-C) is often calculated (cLDL-C) by the Friedewald equation, which requires high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG). Because there have been considerable changes in the measurement of HDL-C with the introduction of direct assays, several alternative equations have recently been proposed.

Methods: We compared 4 equations (Friedewald, Vujovic, Chen, and Anandaraja) for cLDL-C, using 8 different direct HDL-C (dHDL-C) methods. LDL-C values were calculated by the 4 equations and determined by the β quantification reference method procedure in 164 subjects.

Results: For normotriglyceridemic samples (TG<200mg/dl), between 6.2% and 24.8% of all results exceeded the total error goal of 12% for LDL-C, depending on the dHDL-C assay and cLDL-C equation used. Friedewald equation was found to be the optimum equation for most but not all dHDL-C assays, typically leading to less than 10% misclassification of cardiovascular risk based on LDL-C. Hypertriglyceridemic samples (>200mg/dl) showed a large cardiovascular risk misclassification rate (30%-50%) for all combinations of dHDL-C assays and cLDL-C equations.

Conclusion: The Friedewald equation showed the best performance for estimating LDL-C, but its accuracy varied considerably depending on the specific dHDL-C assay used. None of the cLDL-C equations performed adequately for hypertriglyceridemic samples.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Cardiovascular disease risk misclassification by various equations for cLDL-C in samples with TG< 200 mg/dL
Subjects (n=145) with normal serum triglycerides (< 200 mg/dL) were classified into cardiovascular risk categories based on LDL-C performed by the reference method and by the indicated equation and dHDL-C assay. Results are shown as % of participants who were misclassified by cLDL-C into either a lower risk category (hatched bars) or higher risk category (open bars). dHDL-C assays are displayed in ascending order according to increasing total misclassifications. Asterisks (*) indicate the equation that produced the lowest total % misclassification for the indicated dHDL-C assay when compared to other equations, using the same dHDL-C assay. dHDL-C assays: Da, Daiichi; De, Denka; Ky; Kyowa; Ro; Roche; Se; Serotec; Sy, Sysmex; Um, UMA; Wa, Wako.
Figure 2
Figure 2. Cardiovascular disease risk misclassification by various equations for cLDL-C in samples with TG between
200 mg/dL and 400 mg/dL. Subjects (n=19) with serum triglycerides between 200 and 400 mg/dL were classified into cardiovascular risk categories based on LDL-C performed by the reference method and by the indicated equation and dHDL-C assay. Results are shown as % of participants who were misclassified by cLDL-C into either a lower risk category (hatched bars) or a higher risk category (open bars). dHDL-C assays are displayed in ascending order, according to increasing total misclassification. dHDL-C assays: Da, Daiichi; De, Denka; Ky; Kyowa; Ro; Roche; Se; Serotec; Sy, Sysmex; Um, UMA; Wa, Wako.

Similar articles

Cited by

References

    1. Quehenberger O, Dennis EA. The human plasma lipidome. N Engl J Med. 2011;365:1812–1823. - PMC - PubMed
    1. Bachorik PS, Ross JW. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem. 1995;41:1414–1420. - PubMed
    1. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(Suppl 5):S213–256. - PMC - PubMed
    1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA. 2001;285:2486–2497. - PubMed
    1. Branchi A, Rovellini A, Torri A, Sommariva D. Accuracy of calculated serum low-density lipoprotein cholesterol for the assessment of coronary heart disease risk in NIDDM patients. Diabetes Care. 1998;21:1397–1402. - PubMed

Publication types

MeSH terms

-